… Therefore, the development of novel iron chelators as neuroprotective agents for the
treatment of neurodegeneration is an emerging trend. Several iron chelators including 8-…

… Moreover, manganese dyshomoeostasis is also implicated in Parkinson's disease and
other neurodegenerative conditions, such as Alzheimer's disease and Huntington's disease. …

… Cell therapy is also an emerging and promising technology for disease modeling and drug
… have suggested a correlation of pesticides and Parkinson's disease (PD) while genetic and …

… Nowadays, it is well known that the cause behind Parkinson's disease is mainly … ,
factors causing Parkinson's disease as well as future therapies for the cure of the diseases. …

… Parkinson’s disease (PD) is one of the most common neurodegenerative diseases and is
characterized by the loss of dopaminergic (DA) neurons in the striatum and the aggregation of …

… Drug repurposing has emerged as a promising therapeutic strategy to reduce the costs and
safety failures associated with the development of new drugs. … Finally, there is emerging …

… Moreover, cell-based model has also emerged as a feasible disease model for PD. There
are distinct advantages and limitations of each group which determine the suitability of the …

… The current review provides a synthesis of emerging links between insulin resistance and
the pathogenesis of AD and PD and discusses the basis for investigation of antidiabetic agents…

… In conclusion, the findings that emerged from prospective studies designed to investigate
the dietary intake of calories, carbohydrates, proteins, and cholesterol excluded a strong …

Inflammatory responses, including glial cell activation and peripheral immune cell infiltration,
are involved in the pathogenesis of Parkinson’s disease (PD). These inflammatory …